Ernst & Young’s annual Pulse of the Industry report reveals decreasing global revenue and financing in the medtech industry.
The healthcare landscape is changing, and technologies are racing to meet new demands.
The agreement will create a pure-play infusion therapy company.
How advanced software, technology and manufacturing processes will help companies stay competitive.
The deal is part of Johnson & Johnson’s strategy to grow its vision care business.
With differing cultural attitudes towards tissue donation and transplantation, be prepared for some complex hurdles.
Several technologies that can streamline procedures for surgeons in the OR are in development.
The deal will further cement the company’s competitive advantage in providing ‘comprehensive musculoskeletal healthcare’.
The addition of Cosman Medical, a manufacturer of radiofrequency ablation systems, enhances the company’s product line for chronic pain.
As CVD rates rise, so does the demand for devices that improve heart function and blood flow.